Frontiers in Medicine
Beyond lipids: a precision prevention blueprint for China's residual risk

CommentaryBiomarkers
- Colchicine
- Inflammation
- Lipid and ceramide metabolism
- Atherosclerotic cardiovascular disease
- Coronary artery disease
- Humans
The paper
Heilongjiang University of Chinese Medicine; First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Frontiers in Medicine, 17 Aug 2026


